SCHEMBL765358

SCHEMBL765358

CC1CN(CC(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11079865 0.91 KDM4E (0.51)
SCHEMBL11080389 0.85 HSD17B10 (0.41)
SCHEMBL2557014 0.82 L3MBTL1 (0.42)
SCHEMBL24461602 0.80
SCHEMBL10686156 0.79 HSD17B10 (0.38)
SCHEMBL7289985 0.79 POLB (0.49)
SCHEMBL1701604 0.79 POLB (0.49)
SCHEMBL15447586 0.79 POLB (0.49)
SCHEMBL8406208 0.79 POLB (0.49)
SCHEMBL15438887 0.79 POLB (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174653-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2017-06-22 US disclosed
EP-2207775-B1 4-BENZYLAMINO-1-CARBOXYACYL-PIPERIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA OR ARTERIOSCLEROSIS NOVARTIS AG (CH) 2012-03-21 EP disclosed